Select topic…Show allAbout NRASCOVID-19Diet and ExerciseResearchTreatmentSort byNewest – OldestOldest – Newest News, 02 Mar NRAS report on the impact of living with active RA but not being able to access advanced therapies We’re delighted to announce that our report into ‘moderate’ disease has been pubilished in the Rheumatology Advances in Practice, Oxford University Press. “Disease impact of rheumatoid arthritis in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society” Authors: Elena Nikiphorou, Hannah Jacklin, Ailsa Bosworth, Clare Jacklin, Patrick Kiely News, 02 Mar Update on COVID-19 Vaccine We are receiving many calls and enquiries about the vaccine and how that may impact people with RA or JIA. All patients with RA are encouraged to receive a COVID-19 vaccine. This includes people taking Disease Modifying Anti Rhematic Drugs such as methotrexate, sulfasalazine, leflunomide and hydroxychloroquine and/or advanced therapies such as biologics, biosimilars and […] News, 08 Feb Second REUMAVID Survey NRAS are pleased along with Arthritis Action and NASS to be supporting this European study into the impact of COVID19 pandemic on people living with Rheumatic diseases. The survey will take approximately 30 minutes to complete. This study is promoted by the National Axial Spondyloarthritis Society (NASS), the National Rheumatoid Arthritis Society (NRAS), and Arthritis Action, […] News, 02 Feb The new NRAS Website! We have been working hard behind the scenes on improving how we provide information to our Members, supporters and the rheumatoid arthritis (RA) community. Our latest publications, updates and activities for NRAS is a huge support for those who need it. A priority for us and an expectation from those we support is an easy to […] News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain 21/01/2021 The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected […] News, 10 Dec Temporary suspension of some NRAS Services During what is increasingly a difficult time financially for the entire charity/third sector, NRAS has made the difficult decision to put the majority of its employees on furlough leave. We will do all we can to minimise the impact on our beneficiaries and service users, but it will mean that some services are restricted between […] News, 18 Nov Join the DBC’s call in demanding the Government to stop leaving disabled people behind ‘Rishi, we urge you, please – do the right thing’ – over 119,000 demand Chancellor stop denying financial lifeline to 2 million people on legacy benefits. 18/11/2020 Petition hand-in follows Ian Blackford MP telling Prime Minister to ”fix the serious gaps in Covid-19 support for those excluded in the UK” Actor Alun Armstrong behind call […] News, 14 Oct Review published in ‘Musculoskeletal Care’ with contribution from NRAS Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […] News, 01 Oct NRAS Joins Newly Launched World Patients Alliance NRAS is excited to announce that we’ve joined the World Patients Alliance, a new international advocacy coalition of more than 100 patient groups across 38 countries. 01/10/2020 As advocates for individuals impacted by Rheumatoid Arthritis and their loved ones, we know firsthand how patient-centered care makes a difference in healthcare outcomes and patients’ quality of […] News, 21 Sep Covid Choices survey results 1 in 3 people delay medical care in COVID-19 pandemic. Lack of information drives on-going fear of attending appointments. Patients need clear, consistent information about COVID-19 safety measures before going to hospital and GP appointments, according to a public survey led by the Patient Information Forum (PIF). 21/09/2020 More than 800 people responded to the […] 1 2 … 23 Next page
News, 02 Mar NRAS report on the impact of living with active RA but not being able to access advanced therapies We’re delighted to announce that our report into ‘moderate’ disease has been pubilished in the Rheumatology Advances in Practice, Oxford University Press. “Disease impact of rheumatoid arthritis in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society” Authors: Elena Nikiphorou, Hannah Jacklin, Ailsa Bosworth, Clare Jacklin, Patrick Kiely
News, 02 Mar Update on COVID-19 Vaccine We are receiving many calls and enquiries about the vaccine and how that may impact people with RA or JIA. All patients with RA are encouraged to receive a COVID-19 vaccine. This includes people taking Disease Modifying Anti Rhematic Drugs such as methotrexate, sulfasalazine, leflunomide and hydroxychloroquine and/or advanced therapies such as biologics, biosimilars and […]
News, 08 Feb Second REUMAVID Survey NRAS are pleased along with Arthritis Action and NASS to be supporting this European study into the impact of COVID19 pandemic on people living with Rheumatic diseases. The survey will take approximately 30 minutes to complete. This study is promoted by the National Axial Spondyloarthritis Society (NASS), the National Rheumatoid Arthritis Society (NRAS), and Arthritis Action, […]
News, 02 Feb The new NRAS Website! We have been working hard behind the scenes on improving how we provide information to our Members, supporters and the rheumatoid arthritis (RA) community. Our latest publications, updates and activities for NRAS is a huge support for those who need it. A priority for us and an expectation from those we support is an easy to […]
News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain 21/01/2021 The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected […]
News, 10 Dec Temporary suspension of some NRAS Services During what is increasingly a difficult time financially for the entire charity/third sector, NRAS has made the difficult decision to put the majority of its employees on furlough leave. We will do all we can to minimise the impact on our beneficiaries and service users, but it will mean that some services are restricted between […]
News, 18 Nov Join the DBC’s call in demanding the Government to stop leaving disabled people behind ‘Rishi, we urge you, please – do the right thing’ – over 119,000 demand Chancellor stop denying financial lifeline to 2 million people on legacy benefits. 18/11/2020 Petition hand-in follows Ian Blackford MP telling Prime Minister to ”fix the serious gaps in Covid-19 support for those excluded in the UK” Actor Alun Armstrong behind call […]
News, 14 Oct Review published in ‘Musculoskeletal Care’ with contribution from NRAS Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […]
News, 01 Oct NRAS Joins Newly Launched World Patients Alliance NRAS is excited to announce that we’ve joined the World Patients Alliance, a new international advocacy coalition of more than 100 patient groups across 38 countries. 01/10/2020 As advocates for individuals impacted by Rheumatoid Arthritis and their loved ones, we know firsthand how patient-centered care makes a difference in healthcare outcomes and patients’ quality of […]
News, 21 Sep Covid Choices survey results 1 in 3 people delay medical care in COVID-19 pandemic. Lack of information drives on-going fear of attending appointments. Patients need clear, consistent information about COVID-19 safety measures before going to hospital and GP appointments, according to a public survey led by the Patient Information Forum (PIF). 21/09/2020 More than 800 people responded to the […]
Stay up to date Sign up for all the latest JIA and JIA-at-NRAS news and receive our regular monthly emails on the latest research, events and advice. Sign up